Ma. Powzaniuk et al., B-Myb overexpression results in activation and increased Fas/Fas ligand-mediated cytotoxicity of T and NK cells, J IMMUNOL, 167(1), 2001, pp. 242-249
The human B-myb gene encodes a transcriptional regulator that plays an impo
rtant role in cell cycle progression, differentiation, and survival. To ass
ess the in vivo role of B-myb, we investigated the phenotype of mouse trans
genic lines in which B-Myb expression in lymphoid tissues was driven by the
LCK proximal promoter. Overexpression of B-Myb had no measurable effect on
the subsets of splenic and thymic lymphocytes, but was associated with inc
reased expression of Fas ligand in NK and T cells. B-Myb-overexpressing spl
enocytes expressed higher IFN-gamma levels and contained higher percentages
of cytokine-producing cells than wild-type (wt) splenocytes, as detected b
y Western blot analysis and ELISPOT assays, respectively. Ex vivo-cultured
transgenic thymocytes and splenocytes had decreased survival compared with
the corresponding cells from wt mice, possibly dependent on increased expre
ssion of Fas ligand. In addition, Fas ligand-dependent cytotoxicity of tran
sgenic T and NK cells was significantly higher than that mediated by their
wt counterparts. Together, these results indicate that B-Myb overexpression
results in T and NK cell activation and increased cytotoxicity. Therefore,
in addition to its well-established role in proliferation and differentiat
ion, B-myb also appears to be involved in activation of NK and T cells and
in their regulation of Fas/Fas ligand-mediated cytotoxicity The Journal of
Immunology, 2001, 167: 242-249.